Literature DB >> 1085131

Immunologic responses in patients with lepromatous leprosy.

T H Rea, F P Quismorio, B Harding, K M Nies, P J Di Saia, N E Levan, G J Friou.   

Abstract

Immunologic responses were measured in 46 patients with lepromatous leprosy. These patients were not distinguishable from controls on the basis of responses to soluble intradermal antigens, sensitization to contactants, peripheral blood T- and B-cell percentages, in vitro lymphocyte responses to a mitogen, or the prevalence of autoantibodies. Generalized immunologic abnormalities in patients with lepromatous leprosy are neither predisposing causes nor necessary accompaniments of lepromatous leprosy, but are probably remote sequellae of the illness. By implication, the generalized immunologic abnormalities reported in other diseases are likely to be remote sequellae of the particular illness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085131

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  Immunofluorescence studies across the leprosy spectrum.

Authors:  W R Faber; D L Leiker
Journal:  Arch Dermatol Res       Date:  1978-06-29       Impact factor: 3.017

2.  Comparison between autoantibodies in malaria and leprosy with lupus.

Authors:  E Bonfa; R Llovet; M Scheinberg; J M de Souza; K B Elkon
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

Review 3.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

4.  Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  M A Kerr; Y M Hussein; R C Potts; J S Beck; M M Sheriff
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

5.  Lymphocyte transformation test in leprosy: decreased lymphocyte reactivity to Mycobacterium leprae in lepromatous leprosy, with no evidence for a generalized impairment.

Authors:  W R Faber; D L Leiker; I M Nengerman; W P Zeijlemaker; P T Schellekens
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

6.  Suppressed natural killer cell activity during episodes of erythema nodosum leprosum in lepromatous leprosy.

Authors:  R C Humphres; R H Gelber; J L Krahenbuhl
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

7.  The HLA system and leprosy in Thailand.

Authors:  J Greiner; E Schleiermacher; T Smith; V Lenhard; F Vogel
Journal:  Hum Genet       Date:  1978-06-09       Impact factor: 4.132

8.  Immunohistological studies of skin biopsies from patients with lepromatous leprosy.

Authors:  R N Mshana; D P Humber; A Belehu; M Harboe
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

9.  Defect in the generation of cytotoxic T cells in lepromatous leprosy.

Authors:  J L Stach; M Strobel; F Fumoux; J F Bach
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

10.  Defective production of monocyte-activating cytokines in lepromatous leprosy.

Authors:  M A Horwitz; W R Levis; Z A Cohn
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.